{
    "Trade/Device Name(s)": [
        "Olympus IgG Reagent (OSR6X172)",
        "IgG Reagent"
    ],
    "Submitter Information": "Olympus America Inc.",
    "510(k) Number": "K073490",
    "Predicate Device Reference 510(k) Number(s)": [
        "K951013",
        "K050113"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFN"
    ],
    "Summary Letter Date": "December 11, 2007",
    "Summary Letter Received Date": "December 12, 2007",
    "Submission Date": "December 10, 2007",
    "Regulation Number(s)": [
        "21 CFR 866.5510"
    ],
    "Regulation Name(s)": [
        "Immunoglobulins A, G, M, D, E immunological test systems"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "IgG"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [
        "Li-heparin tube",
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Olympus AU400/400",
        "AU600/640/640",
        "AU2700/5400"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric"
    ],
    "Methodologies": [
        "Immunoturbidimetric analysis"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Olympus IgG Reagent (OSR6X172) for quantitative determination of IgG in serum, plasma, and cerebrospinal fluid using immunoturbidimetric methodology on Olympus analyzers",
    "Indications for Use Summary": "System reagent for quantitative determination of IgG immunoglobulins in human serum, plasma, and cerebrospinal fluid on Olympus analyzers; aids diagnosis of abnormal protein metabolism and immune deficiencies",
    "fda_folder": "Immunology"
}